KeyBanc analyst Leo Mariani initiates coverage on Black Stone Minerals (NYSE:BSM) with a Sector Weight rating.
Immutep Filing Shows Co. Received European Medicines Agency Advice For Further Clinical Development Of Efti In Metastatic Breast Cancer, Including Phase 3 Trial
Immutep receives positive EMA scientific advice for
further clinical development of efti in MBC including Phase III
•
Positive feedback for the general clinical development
